Test Guide Mobile Home
Search: Search

Complement C3, C4
Short Description : C3 & C4


Blood
Test performed by: LabPLUS Automation


Specimen Collection

PST

4.5 mL PST Plasma (Preferred)

Micro-PST

0.5 mL Paediatric Micro-PST Blood (Preferred)

Heparin

5 mL Heparin Plasma

Plain

4 mL Adult Plain Blood

SST

3.5 mL SST Serum

Micro-heparin

0.5 mL Paediatric Micro-heparin Blood

.


Reference Intervals
Units: g/L
Age RangeEither Sex
All0.1 - 0.4[1]
0.8 - 1.8[2, 3]

[1]

C4

Please Note: Reference Intervals were updated 25/06/2025 .


[2]

C3


[3] Uncertainty of measurement:

C3 6%

C4 8%
Turnaround Time: 1 day

Roche Cobas turbidimetry method


Diagnostic Use and Interpretation

C3 and C4 should be requested for disorders where complement consumption are suspected.
Inherited complete C3 & C4 deficiencies are extremely rare and best screened for in a specialist setting with the complement pathway activity test.

Raised C3 and C4: May be seen in an acute phase response (systemic inflammation), a significant increase is usually a doubling of the upper limit of the normal range, which may be triggered by a range of infective or inflammatory conditions. Mildly increased complement levels are not likely to have diagnostic clinical utility.

Reduced C3 and/or C4: Please refer to table below

Normal C4 Reduced C4
Normal C3 Normal

Common Causes:
Genetic polymorphism: a null allele or non-expressed C4 gene occurs in 10-16% of healthy people. C4 is typically up to 25% lower than expected, in the absence of other clinical or laboratory features associated with complement consumption.
Reduced C4 alone may also be seen immune complex diseases particularly SLE, vasculitis or cryoglobulinaemia


Uncommon:
C1 inhibitor deficiency (hereditary or acquired angioedema): low C4 is not sensitive nor specific for C1 inhibitor deficiency. C1 inhibitor protein and function should be requested when prior probability of C1 inhibitor deficiency is high; eg. Family history of hereditary angioedema or angioedema without urticaria.


Very uncommon: congenital C4 deficiency

Reduced C3

Uncommon:
C3 nephritic factor (autoantibody). Associated with mesangiocapillary glomerulonephritis and partial lipodystrophy.

Post-streptococcal glomerulonephritis.

Sepsis

Common Causes:
Increased complement consumption eg. active SLE immune-complex glomerulonephritis, cryoglobulinemia, hypocomplementaemic urticarial vasculitis, chronic infection (eg. endocarditis, hepatitis C)


Uncommon:
Severe liver disease; reduced synthesis of complement and other plasma proteins.


Very rare:
Severe capillary leak syndromes; loss of plasma proteins including complement.

References:
1. Ittiprasert, W., Kantachuvesiri, S., Pavasuthipaisit, K., & Verasertniyom, O. (2005). Complete deficiencies of complement C4A and C4B including 2-bp insertion in codon 1213 are genetic risk factors of systemic lupus erythematosus in Thai populations. Journal of Autoimmunity, 25(1), 77-84. https://doi.org/10.1016/j.jaut.2005.04.004
2. Longhurst, H., & Cicardi, M. (2012). Hereditary angio-oedema. The Lancet, 379(9814), 474-481.
3. Wyatt, R., Forristal, J., West, C., Sugimoto, S., & Curd, J. (1998). Complement profiles in acute post-streptococcal glomerulonephritis. Pediatric Nephrology, 2, 219-223. https://doi.org/10.1007/BF00862594
4. Erez, D., Meyers, K., & Sullivan, K. (2017). C3 nephritic factors: A changing landscape. The Journal of Allergy and Clinical Immunology, 140(1), 57-59. https://doi.org/10.1016/j.jaci.2017.02.018
5. Vogel, C., & Fritzinger, D. (2010). Cobra venom factor: Structure, function, and humanization for therapeutic complement depletion. Toxicon, 56(7), 1198-1222. https://doi.org/10.1016/j.toxicon.2010.04.007
6. Kapoor, P., Greipp, P., Schaefer, E., Mandrekar, S., Kamal, A., Gonzalez-Paz, N., Kumar, S., & Greipp, P. (2010). Idiopathic Systemic Capillary Leak Syndrome (Clarkson's Disease): The Mayo Clinic Experience. Mayo Clinic Proceedings, 85(10), 905-912. https://doi.org/10.4065/mcp.2010.0159


Contact Information

The Immunopathology team can be reached via email: immunology@adhb.govt.nz or via Lablink (09) 307 4949 ext 22000:

  • Professor Rohan Ameratunga (Immunopathologist)
  • Dr Maia Brewerton (Immunopathologist)
  • Dr Miriam Hurst (Immunopathologist)
  • Dr Hilary Longhurst (Immunopathologist)


Specimen Transport Instructions for Referring Laboratories

If the delay between taking the specimen and arrival in the testing laboratory is going to be greater than 2 days, The sample is required to be stored at -20 o C immediately after collection and transported frozen to the laboratory . Heparin samples need to be spun and the plasma separated prior to freezing.



Last updated at 14:39:58 29/08/2025